Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
847
-
Total 13F shares, excl. options
-
39,837,799
-
Shares change
-
-1,188,905
-
Total reported value, excl. options
-
$4,687,241,888
-
Value change
-
-$150,124,982
-
Put/Call ratio
-
123%
-
Number of buys
-
285
-
Number of sells
-
-425
-
Price
-
$117.63
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2022
980 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q2 2022.
ISHARES TR - ISHARES BIOTECH (IBB) has 847 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39,837,799 shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (11,152,825 shares), MORGAN STANLEY (3,094,249 shares), CITIGROUP INC (2,061,714 shares), UBS Group AG (1,953,266 shares), ROYAL BANK OF CANADA (1,699,268 shares), GOLDMAN SACHS GROUP INC (1,546,877 shares), BNP PARIBAS ARBITRAGE, SA (922,100 shares), JANE STREET GROUP, LLC (856,014 shares), WELLS FARGO & COMPANY/MN (679,684 shares), and LPL Financial LLC (503,621 shares).
This table shows the top 847 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.